Cendrine Josson

Part of KCAS LLC, Active Biomarkers SASU is a French company that specializes in immuno-monitoring services. The company is based in Lyon, France. The company has a decade of experience in developing and performing assays for immuno-monitoring. Active Biomarkers provides services to support preclinical studies and human clinical trials in immune-related pathologies and neurological disorders. The company is an expert in the development, validation, and testing of assays for soluble or cellular biomarkers. The company's functional assays are designed to help understand the mechanism of action of the drug/therapy, while their pharmacodynamic/pharmacokinetic (pk/pd) assays help to understand the relationship between therapy and the patient biological system. The company was founded in 2011. Marc Essodaigui has been the CEO of the company since 2016. Active Biomarkers was acquired by KCAS LLC on September 12, 2022.

ABL Lyon SAS provides biomarker testing services to advance therapies from discovery to clinical stages. Its services and solutions include immunophenotyping, functional assays, drug-target interactions, study design, sampling plans, and logistics. The company was founded in 2011 and is headquartered in Lyon, France.